5-FU: clinical trials recruiting now
7
Recruiting trials
6
Conditions studied
3
US states with sites
3
Countries
Phase breakdown
Phase 1 3
Phase 2 4
Phase 3 1
Conditions being studied
Recruiting trials involving 5-FU
- A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer
- A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer
- ARTEMIS-102: HS-20093 Combinations in Patients with Advanced Metastatic Colorectal Cancer
- Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LV
- Liposomal Irinotecan and Leucovorin/5-fluorouracil Plus Bevacizumab in Metastatic Colorectal Cancer
- Phase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic Colorectal Cancer
- Study of Petosemtamab Plus Chemotherapy Versus Cetuximab or Bevacizumab Plus Chemotherapy in RAS and BRAF Wild Type, Recurrent, Unresectable or Metastatic Colorectal Cancer (LiGeR-CRC2)
Common questions
How many recruiting trials involve 5-FU?
7 recruiting trials across 6 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.